Historical record - last NADAC effective date: 11/18/2020
Product Information
NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1426 per ML under NDC 51672411704. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Feb 29, 1988.
Strength
100000 [USP'U]/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672411704
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
11/18/2020
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA062876FDA Approved
2/29/1988
On Market Since
2/29/1988
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 367 times since Nov 28, 2013, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1426 per ML |
|---|---|
| All-time high | $0.1822 (Feb 12, 2014) |
| All-time low | $0.1114 (Apr 17, 2019) |
| Median price | $0.1346 |
| Average price | $0.1409 |
| Largest weekly change | +20.7% (Aug 19, 2020) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.8%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1426 per ML (NDC 51672411704), effective Dec 2, 2020.
How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 18.8%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?
Since Nov 28, 2013, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.1114 (Apr 17, 2019) to a high of $0.1822 (Feb 12, 2014), with a median of $0.1346 per ML.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0569 per ML — about 60% below NYSTATIN 100,000 UNIT/ML SUSP.
Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?
NYSTATIN 100,000 UNIT/ML SUSP (NDC 51672411704) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.